Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors

Sophie H Bots, Michelle M Schreuder, Jeanine E Roeters van Lennep, Sarah Watson, Eugène van Puijenbroek, N Charlotte Onland-Moret, Hester M den Ruijter

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This cross-sectional study investigates differences by sex in reporting of adverse drug reactions associated with angiotensin-converting enzyme inhibitors combining global and prescription-corrected databases.

Original languageEnglish
Article numbere228224
Pages (from-to)1-4
Number of pages4
JournalJAMA network open
Volume5
Issue number4
DOIs
Publication statusPublished - 20 Apr 2022

Bibliographical note

Funding Information:
Funding/Support: This work was supported by grant 2020B004 from the Dutch CardioVascular Alliance and European Research Council Consolidator grant 866478.

Keywords

  • Angiotensin Receptor Antagonists/adverse effects
  • Angiotensin-Converting Enzyme Inhibitors/adverse effects
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • Humans
  • Male
  • Sex Characteristics

Fingerprint

Dive into the research topics of 'Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors'. Together they form a unique fingerprint.

Cite this